Postpartum bleeding

Postpartum bleeding
Other namesPostpartum hemorrhage
A non-pneumatic anti-shock garment (NASG)
SpecialtyObstetrics
SymptomsSignificant blood loss after childbirth, increased heart rate, feeling faint upon standing, increased breath rate[1][2]
CausesPoor contraction of the uterus, not all the placenta removed, tear of the uterus, poor blood clotting[2]
Risk factorsAnemia, Asian ethnicity, more than one baby, obesity, age older than 40 years[2]
PreventionOxytocin, misoprostol[2]
TreatmentIntravenous fluids, non-pneumatic anti-shock garment, blood transfusions, ergotamine, tranexamic acid[2][3]
Prognosis3% risk of death (developing world)[2]
Frequency8.7 million (global)[4] / 1.2% of births (developing world)[2]
Deaths83,100 (2015)[5]

Postpartum bleeding or postpartum hemorrhage (PPH) is significant blood loss following childbirth. It is the most common cause of maternal death worldwide, disproportionately affecting developing countries.[6] Definitions and criteria for diagnosis are highly variable.[2][7] PPH is defined by the World Health Organization as "blood loss of 500 ml or more within 24 hours after birth",[8] though signs of shock (insufficient blood flow) have also been used as a definition.[7] Some bleeding after childbirth is normal and is called lochia. It is difficult to distinguish lochia from delayed PPH.[9]

Signs and symptoms of PPH may initially include: an increased heart rate, feeling faint upon standing, and an increased breathing rate. As more blood is lost, the patient may feel cold, blood pressure may drop, and they may become restless or unconscious.[1] In severe cases circulatory collapse, disseminated intravascular coagulation and death can occur. The condition can occur up to twelve weeks following delivery in the secondary form.[10]

The most common cause of PPH is insufficient contraction of the uterus following childbirth; this contraction normally stops the blood flow that supplies the fetus during pregnancy. Other causes are retained placenta, where the placenta is not expelled after childbirth; a tear of the uterus, cervix, or vagina; or poor blood clotting. PPH is more likely to occur in people who are Asian, are obese, previously had PPH or have an anemia, give birth to a large baby or more than one fetus, or are older than 40 years of age.[2] It also occurs more commonly following caesarean sections, those in whom medications are used to start labor, those requiring the use of a vacuum or forceps, and those who have an episiotomy.[2][11]

Prevention involves decreasing known risk factors including procedures associated with the condition, if possible, and giving the medication oxytocin to stimulate the uterus to contract shortly after the baby is born.[2] Misoprostol may be used instead of oxytocin in resource-poor settings.[2] Treatments may include: intravenous fluids, blood transfusions, and the medication ergotamine to cause further uterine contraction.[2] Efforts to compress the uterus using the hands may be effective if other treatments do not work.[2] The aorta may also be compressed by pressing on the abdomen.[2] The World Health Organization has recommended the non-pneumatic anti-shock garment to help until other measures such as surgery can be carried out.[2] Tranexamic acid has also been shown to reduce the risk of death,[12] and has been recommended within three hours of delivery.[13]

In the developing world about 1.2% of deliveries are associated with PPH and when PPH occurred about 3% of women died.[2] It is responsible for 8% of maternal deaths during childbirth in developed regions and 20% of maternal deaths during childbirth in developing regions.[10] Globally it occurs about 8.7 million times and results in 44,000 to 86,000 deaths per year making it the leading cause of death during pregnancy.[4][2][14] About 0.4 women per 100,000 deliveries die from PPH in the United Kingdom while about 150 women per 100,000 deliveries die in sub-Saharan Africa.[2] Rates of death have decreased substantially since at least the late 1800s in the United Kingdom.[2]

  1. ^ a b Lynch, Christopher B- (2006). A textbook of postpartum hemorrhage : a comprehensive guide to evaluation, management and surgical intervention. Duncow: Sapiens Publishing. pp. 14–15. ISBN 9780955228230. Archived from the original on 2016-08-15.
  2. ^ a b c d e f g h i j k l m n o p q r s t Weeks, A (January 2015). "The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?". BJOG: An International Journal of Obstetrics and Gynaecology. 122 (2): 202–10. doi:10.1111/1471-0528.13098. PMID 25289730. S2CID 32538078.
  3. ^ Cite error: The named reference [ was invoked but never defined (see the help page).
  4. ^ a b GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. (8 October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
  5. ^ GBD 2015 Mortality and Causes of Death Collaborators. (8 October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
  6. ^ Cresswell, Jenny A; Alexander, Monica; Chong, Michael Y C; Link, Heather M; Pejchinovska, Marija; Gazeley, Ursula; Ahmed, Sahar M A; Chou, Doris; Moller, Ann-Beth; Simpson, Daniel; Alkema, Leontine; Villanueva, Gemma; Sguassero, Yanina; Tunçalp, Özge; Long, Qian (April 2025). "Global and regional causes of maternal deaths 2009–20: a WHO systematic analysis". The Lancet Global Health. 13 (4): e626 – e634. doi:10.1016/S2214-109X(24)00560-6. PMC 11946934. PMID 40064189.
  7. ^ a b Gibbs, Ronald S (2008). Danforth's obstetrics and gynecology (10th ed.). Philadelphia: Lippincott Williams & Wilkins. p. 453. ISBN 9780781769372. Archived from the original on 2016-06-05.
  8. ^ Cite error: The named reference :3 was invoked but never defined (see the help page).
  9. ^ Fletcher, Susan; Grotegut, Chad A.; James, Andra H. (December 2012). "Lochia Patterns Among Normal Women: A Systematic Review". Journal of Women's Health. 21 (12): 1290–1294. doi:10.1089/jwh.2012.3668. ISSN 1540-9996.
  10. ^ a b Bienstock, Jessica L.; Eke, Ahizechukwu C.; Hueppchen, Nancy A. (29 April 2021). "Postpartum Hemorrhage". New England Journal of Medicine. 384 (17): 1635–1645. doi:10.1056/NEJMra1513247. PMC 10181876. PMID 33913640.
  11. ^ Lockhart, E (2015). "Postpartum hemorrhage: a continuing challenge". Hematology. American Society of Hematology. Education Program. 2015 (1): 132–7. doi:10.1182/asheducation-2015.1.132. PMID 26637712.
  12. ^ Shakur, Haleema; Roberts, Ian; Fawole, Bukola (April 2017). "Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial". The Lancet. 389 (10084): 2105–2116. doi:10.1016/S0140-6736(17)30638-4. PMC 5446563. PMID 28456509.
  13. ^ World Health Organization (October 2017). "Updated WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage" (PDF). World Health Organization. Retrieved 2020-04-11.
  14. ^ GBD 2013 Mortality and Causes of Death Collaborators (17 December 2014). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.